SEARCH
Q3 Review: Analysing Aarti Drugs' Report Card | BQ Prime
NDTV Profit
2023-01-30
Views
3
Description
Share / Embed
Download This Video
Report
#Q3WithBQ | #AartiDrugs' profit slides 37% year-on-year as formulation and specialty chemicals see revenue contraction.
In conversation with CFO Adhish P Patil. #BQLive
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x8hp5de" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
12:36
Q3 Review | How Titan Could Perform In Q4 FY23 & Beyond | BQ Prime
20:32
KPIT Tech's Co-founder Kishor Patil On Q3 Report Card & Outlook On FY23
13:44
Analysing TCS' Q3 Report Card | BQ Prime
09:43
Q3 Review: Analysing Aarti Industries Third Quarter Report Card
02:55
What Sunil Patil said over allegations on him in drugs case
04:45
मनिष भानुशालीने दिल्लीत डांबून ठेवलं, मारहाण केली; Sunil Patil यांचा दावा | Aryan Khan Drugs Case
05:09
Aarti Drugs Is Aiming For Double Digit Growth In FY19
26:54
Earnings Edge | Rainbow Hospitals, Ujjivan SFB, Aarti Drugs | NDTV Profit
05:03
Aarti Drugs: Muted Quarter
07:47
Aarti Drugs Expects Volume Growth In Fourth Quarter And Beyond
00:00
Earnings Edge | Rainbow Hospitals, Ujjivan SFB, Aarti Drugs | NDTV Profit
01:52
Ulta Beauty Q3 Earnings Highlights: Shares Are Trading Higher After The Company Reported Better-Than-Expected Q3 Sales Results And Revised FY23 Guidance
